Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 25 /hr
Hire Dr. Cristiano G.
Brazil
USD 25 /hr
Profile Summary
Summary details not provided.
Subject Matter Expertise
Services
Work Experience
Business Intelligence Specialist
Instituto Butantan
April 2019 - Present
TTO Researcher
SUPERA Park of Innovation and Technology of Ribeirão Preto
June 2018 - Present
Education
Post Doctoral (Departamento de Administração)
Universidade de São Paulo Faculdade de Economia Administração e Contabilidade de Ribeirão Preto
December 2014 - Present
Doctor/PhD (Departamento de Biologia Celular e Molecular)
Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto
November 2010 - December 2014
Master (Departamento de Biologia Celular e Molecular)
Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto
August 2008 - November 2010
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
(2019). Emerging CAR T cells therapies: clinical landscape and patent technological routes . Human Vaccines & Immunotherapeutics.
Pereira CG, Picanco-Castro V, Covas DT, Porto GS(2018). Patent mining and landscaping of emerging recombinant factor VIII through network analysis . Nature biotechnology.
(2018). Forecasting of emerging therapeutic monoclonal antibodies patents based on a decision model . Technological Forecasting and Social Change.
(2018). Forecasting of emerging therapeutic monoclonal antibodies patents based on a decision model . Technological Forecasting and Social Change.
(2018). Patent mining and landscaping of emerging recombinant factor VIII through network analysis . Nature Biotechnology. 36. (7). p. 585-590.
(2017). Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation . Cell Biology and Toxicology. 33. (3). p. 233-250.
(2016). RMEL3, a novel BRAF<sup>V600E</sup>-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma . Oncotarget. 7. (24). p. 36711-36718.
Pereira, Cristiano Gonçalves, Pereira, Cristiano Gonçalves, da Silva, Rodrigo Ribeiro, Porto, Geciane Silveira(2015). The scientific information provided through patents and its limited use in scientific research at universities . Brazilian Journal of Science and Technology. 2. (1). p. 1-11.
(2014). Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target . Clinical Cancer Research. 20. (21). p. 5537-5546.
(2014). Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanoma . Cancer Research. 74. (23). p. 7037-7047.
(2014). The involvement of heparin in retinal infection by Toxoplasma gondii in a chick model revealed an ontogenetic-dependent pattern . Parasitology International. 63. (2). p. 337-340.
(2011). Effects of Bothrops moojeni venom on Leishmania amazonensis promastigote forms . Journal of Venomous Animals and Toxins Including Tropical Diseases. 17. (2). p. 150-158.
(2010). Novel primate-specific genes, RMEL 1, 2 and 3, with highly restricted expression in melanoma, assessed by new data mining tool . PLoS ONE. 5. (10).
(2009). Different isolates from Leishmania braziliensis complex induce distinct histopathological features in a murine model of infection . Veterinary Parasitology. 165. (3-4). p. 231-240.
(2008). Detection of IFN-gamma, CXCR3 and CCR5 in renal biopsies of patients with glomerulopathies . Tissue Antigens. 71. (4). p. 335.
(2007). A typical presentation of cutaneous leishmaniasis after renal transplantation [8] . Nephrology Dialysis Transplantation. 22. (12).
Technological cooperation network in biotechnology: Analysis of patents with Brazil as the priority country . Innovation \& Management Review. 0. (0). p. null.
Cardoso, Cibele and Serafim, Rodolfo B. and Kawakami, Akinori and Pereira, Cristiano Gonçalves and Roszik, Jason and Valente, Valeria and Vazquez, Vinicius L. and Fisher, David E. and Espreafico, Enilza M. The lncRNA RMEL3 protects immortalized cells from serum withdrawal-induced growth arrest and promotes melanoma cell proliferation and tumor growth . Pigment Cell & Melanoma Research. 0. (ja).
BOOK
(2018). Uncovering innovation features and emerging technologies in molecular biology through patent analysis . Methods in Molecular Biology. 1674. p. 15-34.
BOOK CHAPTER
Pereira, Cristiano Gonçalves, Porto, Geciane Silveira(2018). Uncovering Innovation Features and Emerging Technologies in Molecular Biology through Patent Analysis . Recombinant Glycoprotein Production: Methods and Protocols. p. 15-34.
CONFERENCE PAPER
C. G. Pereira and J. Lavoie and E. Garces and M. Dabic and G. S. Porto and T. Daim(2018). Assessment of biotechnologies: a therapeutic monoclonal antibody emerging score . 2018 IEEE Technology and Engineering Management Conference (TEMSCON). p. 1-6.